S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
$115.70
-0.7%
$122.81
$90.73
$135.45
$20.24B1.05999,192 shs951,526 shs
GBF
iShares Government/Credit Bond ETF
$101.04
+0.3%
$102.83
$96.03
$106.41
$151.56M0.1328,349 shs2,399 shs
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
$0.38
$0.39
$0.19
$2.65
$6.64M3.081.39 million shs38,597 shs
Kaleyra, Inc. stock logo
KLR
Kaleyra
$7.24
$0.00
$1.57
$7.25
$96.51M1.75147,441 shsN/A
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
+0.05%-5.96%-5.67%-5.55%-6.97%
GBF
iShares Government/Credit Bond ETF
-0.35%-0.57%-2.05%-3.01%-3.96%
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
+2.72%-8.52%-5.55%-2.88%-58.94%
Kaleyra, Inc. stock logo
KLR
Kaleyra
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
4.1999 of 5 stars
2.42.04.22.03.42.51.3
GBF
iShares Government/Credit Bond ETF
N/AN/AN/AN/AN/AN/AN/AN/A
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
N/AN/AN/AN/AN/AN/AN/AN/A
Kaleyra, Inc. stock logo
KLR
Kaleyra
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
2.88
Moderate Buy$137.1318.52% Upside
GBF
iShares Government/Credit Bond ETF
0.00
N/AN/AN/A
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
2.00
HoldN/AN/A
Kaleyra, Inc. stock logo
KLR
Kaleyra
N/AN/AN/AN/A

Current Analyst Ratings

Latest ARE, HILS, GBF, MGNS, and KLR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
1/31/2024
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$140.00
1/31/2024
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$140.00
1/30/2024
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$140.00
(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
$2.89B7.01$6.36 per share18.18$129.20 per share0.90
GBF
iShares Government/Credit Bond ETF
N/AN/AN/AN/AN/AN/A
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
N/AN/AN/AN/A$0.48 per shareN/A
Kaleyra, Inc. stock logo
KLR
Kaleyra
$339.17M0.28$0.99 per share7.31$3.26 per share2.22

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
$103.64M$0.54214.2611.812.663.59%0.46%0.28%4/22/2024 (Confirmed)
GBF
iShares Government/Credit Bond ETF
N/AN/A0.00N/AN/AN/AN/AN/A
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
-$8.47M-$0.72N/AN/AN/AN/A-188.44%-149.61%N/A
Kaleyra, Inc. stock logo
KLR
Kaleyra
-$98.53M-$6.84N/AN/AN/A-25.46%-57.22%-7.60%N/A

Latest ARE, HILS, GBF, MGNS, and KLR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/22/2024N/A
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
$2.31N/A-$2.31N/AN/AN/A  
1/30/202412/31/2023
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
$2.29-$0.54-$2.83-$0.54$740.16 million$757.22 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
$5.084.39%+5.37%940.76%14 Years
GBF
iShares Government/Credit Bond ETF
$2.182.16%N/AN/AN/A
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
N/AN/AN/AN/AN/A
Kaleyra, Inc. stock logo
KLR
Kaleyra
N/AN/AN/AN/AN/A

Latest ARE, HILS, GBF, MGNS, and KLR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/4/2024
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
quarterly$1.274.03%3/27/20243/28/20244/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
0.50
0.26
0.26
GBF
iShares Government/Credit Bond ETF
N/AN/AN/A
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
N/A
3.01
3.01
Kaleyra, Inc. stock logo
KLR
Kaleyra
7.67
1.39
1.39

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
568174.95 million172.94 millionOptionable
GBF
iShares Government/Credit Bond ETF
N/A1.50 millionN/ANot Optionable
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
117.60 million12.28 millionNot Optionable
Kaleyra, Inc. stock logo
KLR
Kaleyra
62013.33 million9.17 millionNot Optionable

ARE, HILS, GBF, MGNS, and KLR Headlines

SourceHeadline
Web Real Time Communication Solution Market to Soar: $9.3 Billion Projected in 2023, 44.2% CAGR Expected Through 2033Web Real Time Communication Solution Market to Soar: $9.3 Billion Projected in 2023, 44.2% CAGR Expected Through 2033
fmiblog.com - February 27 at 2:50 PM
Tata Communications completes acquisition of Kaleyra, a leading global CPaaS platform playerTata Communications completes acquisition of Kaleyra, a leading global CPaaS platform player
finance.yahoo.com - October 5 at 10:03 AM
Kaleyra Appointed by stc Bahrain As Exclusive Omnichannel PartnerKaleyra Appointed by stc Bahrain As Exclusive Omnichannel Partner
finance.yahoo.com - September 21 at 8:41 AM
Kaleyra (KLR) Surges 6.2%: Is This an Indication of Further Gains?Kaleyra (KLR) Surges 6.2%: Is This an Indication of Further Gains?
finance.yahoo.com - September 20 at 10:50 PM
Kaleyra, Inc. Special Meeting Reminder and Announcement of Recommendations by ISS and Glass Lewis that Stockholders Vote FOR the Proposed MergerKaleyra, Inc. Special Meeting Reminder and Announcement of Recommendations by ISS and Glass Lewis that Stockholders Vote FOR the Proposed Merger
finance.yahoo.com - September 20 at 9:31 AM
Moore Kuehn Encourages CELL, CCF, IMNM, and KLR Investors to Contact Law FirmMoore Kuehn Encourages CELL, CCF, IMNM, and KLR Investors to Contact Law Firm
benzinga.com - September 11 at 12:55 PM
KALEYRA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kaleyra, Inc. - KLRKALEYRA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kaleyra, Inc. - KLR
businesswire.com - August 28 at 3:04 PM
Kaleyra and Talisma Partner in India to Enhance Customer Experience with Real-Time Video and Co-BrowsingKaleyra and Talisma Partner in India to Enhance Customer Experience with Real-Time Video and Co-Browsing
finance.yahoo.com - August 22 at 8:21 AM
Kaleyra Announces Changes in Management TeamKaleyra Announces Changes in Management Team
finance.yahoo.com - August 11 at 5:06 PM
Kaleyra US: Kaleyra Announces Second Quarter 2023 ResultsKaleyra US: Kaleyra Announces Second Quarter 2023 Results
finanznachrichten.de - August 8 at 7:25 AM
Kaleyra Announces Second Quarter 2023 ResultsKaleyra Announces Second Quarter 2023 Results
finance.yahoo.com - August 8 at 2:24 AM
Kaleyra Brings WhatsApp Business Platform To US Solution Portfolio To Enhance Customer EngagementKaleyra Brings WhatsApp Business Platform To US Solution Portfolio To Enhance Customer Engagement
finance.yahoo.com - July 26 at 6:00 PM
Northland Capital Markets Downgrades Kaleyra (KLR)Northland Capital Markets Downgrades Kaleyra (KLR)
msn.com - July 7 at 12:20 PM
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Kaleyra, Inc. (NYSE – KLR)SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Kaleyra, Inc. (NYSE – KLR)
benzinga.com - July 6 at 8:39 PM
Kaleyra (KLR) Price Target Increased by 19.81% to 10.79Kaleyra (KLR) Price Target Increased by 19.81% to 10.79
msn.com - July 6 at 3:38 PM
Moore Kuehn Encourages AMED, KLR, SGTX, and WAKE Investors to Contact Law FirmMoore Kuehn Encourages AMED, KLR, SGTX, and WAKE Investors to Contact Law Firm
benzinga.com - July 5 at 4:53 PM
IMPORTANT ALERT: Halper Sadeh LLC Investigates KLR, WMC, SGTXIMPORTANT ALERT: Halper Sadeh LLC Investigates KLR, WMC, SGTX
bakersfield.com - July 3 at 3:39 PM
KLR stock rated a Hold by Craig HallumKLR stock rated a Hold by Craig Hallum
knoxdaily.com - July 3 at 9:41 AM
Tata Communications Acquiring Kaleyra, Formerly Ubiquity That Acquired An Indian Startup in 2016Tata Communications Acquiring Kaleyra, Formerly Ubiquity That Acquired An Indian Startup in 2016
indianweb2.com - June 30 at 12:32 PM
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Kaleyra, Inc. BuyoutSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Kaleyra, Inc. Buyout
barrons.com - June 30 at 7:32 AM
Tata Communications To Acquire This New York Stock Exchange-Listed Company For $100 MillionTata Communications To Acquire This New York Stock Exchange-Listed Company For $100 Million
goodreturns.in - June 29 at 2:07 PM
Tata Communications to acquire CPaaS platform player, Kaleyra, in all-cash transactionTata Communications to acquire CPaaS platform player, Kaleyra, in all-cash transaction
telecomtv.com - June 29 at 9:03 AM
KLR stock price expected to increase by $12.38 in 12 monthsKLR stock price expected to increase by $12.38 in 12 months
knoxdaily.com - June 29 at 9:03 AM
Shareholder Alert: Ademi LLP investigates whether Kaleyra, Inc. has obtained a Fair Price in its transaction with Tata CommunicationsShareholder Alert: Ademi LLP investigates whether Kaleyra, Inc. has obtained a Fair Price in its transaction with Tata Communications
benzinga.com - June 29 at 9:03 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Alexandria Real Estate Equities logo

Alexandria Real Estate Equities

NYSE:ARE
Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. As the pioneer of the life science real estate niche since our founding in 1994, Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative life science, agtech, and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. Alexandria has a total market capitalization of $33.1 billion and an asset base in North America of 73.5 million SF as of December 31, 2023, which includes 42.0 million RSF of operating properties, 5.5 million RSF of Class A/A+ properties undergoing construction and one near-term project expected to commence construction in the next two years, 2.1 million RSF of priority anticipated development and redevelopment projects, and 23.9 million SF of future development projects. Alexandria has a longstanding and proven track record of developing Class A/A+ properties clustered in life science, agtech, and advanced technology mega campuses that provide our innovative tenants with highly dynamic and collaborative environments that enhance their ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science, agrifoodtech, climate innovation, and technology companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.

iShares Government/Credit Bond ETF

NYSEARCA:GBF
iShares Government/Credit Bond ETF (the Fund) is an exchange-traded fund. The Fund seeks to track the investment results of an index composed of the United States dollar-denominated government, government-related and investment-grade the United States corporate bonds. The Fund seeks to track the investment results of the Barclays U.S. Government/Credit Bond Index (the Underlying Index), which measures the performance of the United States dollar-denominated United States Treasury bonds, government-related bonds (i.e., the United States and foreign agencies, sovereign, supranational and local authority debt) and investment-grade United States corporate bonds, which have a remaining maturity of greater than or equal to one year. The Underlying Index may include large-, mid- or small-capitalization companies, and components include agency and treasury securities, and financial and industrials companies. BlackRock Fund Advisors serves as investment adviser of the Fund.
Hillstream BioPharma logo

Hillstream BioPharma

NASDAQ:HILS
Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) and targeted immuno-oncology novel biologics for the treatment drug resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors. It also develops HSB-3215, an anti-HER2 monoclonal antibody candidate; and HSB-1940, a Quatrabody that is a proprietary IO biologic in development targeting PD-1. The company was incorporated in 2017 and is based in Bridgewater, New Jersey.
Kaleyra logo

Kaleyra

NYSEAMERICAN:KLR
Kaleyra Inc., through its subsidiaries, provides mobile communication services to financial institutions, e-commerce players, OTTs, software companies, logistic enablers, healthcare providers and retailers, and other organization worldwide. The company provides cloud communications platforms, which manages multi-channel integrated communications services including inbound/outbound messaging solutions, programmable voice and interactive voice response configurations, hosted telephone numbers, conversational marketing solutions, rich communication services, and other IP communications, such as e-mail, push notifications, video/audio/chat, and WhatsApp services. It also enables its customers and business partners to connect enterprise software and applications to mobile network operators through application programming interfaces, which allows to build omnichannel. In addition, the company provides set of no-coding cloud-based visual interfaces to program communications to customers across multiple channels. Kaleyra, Inc. was founded in 1999 and is headquartered in Milan, Italy.